Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAVABOROLE for Dermatophytosis of nail: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where TAVABOROLE was used for Dermatophytosis of nail.

Most Reported Side Effects for TAVABOROLE

Side Effect Reports % Deaths Hosp.
Drug ineffective 129 18.1% 0 0
Application site erythema 71 10.0% 0 0
Application site exfoliation 56 7.9% 0 0
Application site pain 54 7.6% 0 0
Application site irritation 40 5.6% 0 0
Nail discolouration 38 5.3% 0 0
Drug administered at inappropriate site 37 5.2% 0 2
Erythema 36 5.1% 0 0
Pruritus 36 5.1% 0 0
Skin exfoliation 30 4.2% 0 0
Hypersensitivity 27 3.8% 0 0
Ingrowing nail 25 3.5% 0 0
Accidental exposure to product 21 3.0% 0 1
Nail disorder 19 2.7% 0 0
Onychomadesis 19 2.7% 0 0

Other Indications for TAVABOROLE

Onychomycosis (308) Fungal infection (51) Product used for unknown indication (10) Fungal skin infection (5) Nail disorder (5)

Other Drugs Used for Dermatophytosis of nail

TERBINAFINE (108) ITRACONAZOLE (48) EFINACONAZOLE (31) FLUCONAZOLE (5)

Related Pages

TAVABOROLE Full Profile All Dermatophytosis of nail Drugs TAVABOROLE Demographics TAVABOROLE Timeline